Trader Talk With Art Cashin 4.13.10
Airtime: Tues. Apr. 13 2010 | 8:50 AM ET
Art Cashin, director of floor operations at UBS, has the buzz from the NYSE.
Similar Posts
Study Identifies Heart Risks in Glaxo's Avandia
Study Identifies Heart Risks in Glaxo’s Avandia. Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial study identifying heart risks in GlaxoSmithKline’s Avandia diabetes drug. He talks to CNBC’s Mike Huckman.
Governments 'Will Bankrupt Us': Dr Gloom
The world is doomed because the governments are taking over and will bankrupt us, says Marc Faber, editor & publisher at The Gloom, Boom & Doom Report. He also tells co-guest host Michael Yoshikami, founder, president and chief investment strategist at YCMNet Advisor, CNBC’s Bernard Lo and Karen Tso, that the Goldman fraud case was mainly political.
April Consumer Price Index
Getting a check on inflation, with CNBC’s Rick Santelli.
Markets Digest Housing Data
Insight on the markets following the release of housing starts data, with CNBC’s Rick Santelli.
Basel III Breakdown
The new banking rules will bring some stability to the financial system, believes Kirby Daley, senior strategist, Newedge Group. He shares his thoughts with Karsten Schroeder, CEO, Amplitude Capital, CNBC’s Martin Soong and Sri Jegarajah.
Canada's Central Banker
Bank of Canada Governor Mark Carney is the only central banker in the G7 to raise interest rates this year, with CNBC’s Steve Liesman, and Mark Carney, Bank of Canada governor.
